Fondsfinans Global Helse B

Buy

Fondsfinans Global Helse is an actively managed global equity fund that invests in large and liquid companies within the healthcare sector. The fund's objective is to deliver strong risk-adjusted return in the long run. The fund invests in listed companies within pharmaceuticals, biotechnology, medical equipment and healthcare services. Investments in foreign currency are not hedged. For more information, see the fund's prospectus.

Opens in a new windowFact sheet
Opens in a new windowProspectus
Opens in a new windowKey information document (English)

Managers

Preben Bang

Preben Bang (Has managed the fund since: 01-01-2022)

Preben Bang holds a Master's degree in Physics and Mathematics, and has completed further studies as a CFA charterholder and fixed income analyst. Preben previously worked at NBIM with a focus on risk management and quantitative financial analysis. Bang joined Fondsfinans Kapitalforvaltning in December 2021.

Fund facts

Fund category

Equity

Morningstar rating

Morningstar Rating är 3 av 5 stjärnor

Comparison index

No benchmark

Country of registration

Norway

Fund assets (30-06-2026)

563 MNOK

Fund start date

23-05-2024

Trading currency

NOK

ISIN

NO0013168740

UCITS

Ja

Close price (23-07-2026)

64 640,4460 NOK

Managers

Preben Bang

As of 30-06-2026

Region

North America
Europe
Asia

10 largest holdings

USIcon PLC
CHRoche Holding AG Ordinary Shares new
USEli Lilly and Co
USUnitedHealth Group Inc
USMerck & Co Inc
GBGSK PLC ADR
USGilead Sciences Inc
USJohnson & Johnson
USRoyalty Pharma PLC Class A
USThe Cigna Group

Total: 29 holdings

See the full portfolio

Industry

Healthcare
Industry

99,61% of the content of the funds analyzed

Style

Large Value Companies
Mid-sized mixed companies
Mid-sized value companies
Large, mixed companies
Small cap companies
Large growth companies
Small, mixed companies
Mid-cap growth companies

99,61% of the content of the funds analyzed

Asset Allocation

Stocks
Cash

100% of the content of the funds analyzed

Management fee

+ p. fee

Procentandel: + p. fee

Subscription fee

Redemption fee

Prisen på fondet har betydning for fondets fremtidige avkastning. Fondet belastes med et løpende forvaltningshonorar gitt i tabellen over. Eksempelvis vil en investering på kr 100.000 i dette fondets tilfelle med 0% i avkastning gi en årlig kostnad på kr 700 i honorar. I tillegg kommer eventuelt resultatavhengig forvaltingsgodtgjørelse.

Risk

1234567

Sharpe ratio

Standard deviation 3 years

Tracking error 3 years

Information ratio 3 years

Sustainability risk

CO2 risk value
UN PRI
Ja
SFDR
8

Product exclusions

NBIM's exclusion list
NBIM's exclusion list
Tobacco or tobacco products
Tobacco or tobacco products
Pornographic material
Pornographic material
Alcoholic beverages
Alcoholic beverages
Gambling as core business
Gambling as core business
Cannabis for intoxicating purposes
Cannabis for intoxicating purposes
Companies that produce weapons that in normal use violate basic humanitarian principles
Companies that produce weapons that in normal use violate basic humanitarian principles
Companies that sell military equipment to sanctioned regimes
Companies that sell military equipment to sanctioned regimes
Companies that contribute to gross or systematic violations of labor and human rights (including child labor or other exploitation of children)
Companies that contribute to gross or systematic violations of labor and human rights (including child labor or other exploitation of children)
Gross corruption
Gross corruption
Other gross violations of fundamental ethical norms
Other gross violations of fundamental ethical norms
Contributes to serious environmental damage
Contributes to serious environmental damage